Immunohistochemical panel for distinguishing esophageal adenocarcinoma from squamous cell carcinoma: A combination of p63, cytokeratin 5/6, MUC5AC, and anterior gradient homolog 2 allows optimal subtyping

Human Pathology

Volumn 43, Issue 11, 2012, Pages 1799-1807

  Dimaio, Michael A ^a   Kwok, Shirley ^a   Montgomery, Kelli D ^a   Lowe, Anson W ^a   Pai, Reetesh K ^b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Carcinoma; Esophagus; Immunohistochemistry; Subtyping

Indexed keywords

ANTERIOR GRADIENT HOMOLOG 2 PROTEIN; CYTOKERATIN 5; CYTOKERATIN 6; CYTOKERATIN 7; MUCIN 2; MUCIN 5AC; PROTEIN; PROTEIN P63; TRANSCRIPTION FACTOR CDX2; TRANSCRIPTION FACTOR SOX2; UNCLASSIFIED DRUG;

ARTICLE; CANCER GRADING; CLINICAL ARTICLE; CONTROLLED STUDY; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; PROTEIN EXPRESSION; TISSUE MICROARRAY;

ADENOCARCINOMA; CARCINOMA, SQUAMOUS CELL; DIAGNOSIS, DIFFERENTIAL; ESOPHAGEAL NEOPLASMS; ESOPHAGOGASTRIC JUNCTION; HUMANS; KERATINS; MUCIN 5AC; PROTEINS; SENSITIVITY AND SPECIFICITY; TISSUE ARRAY ANALYSIS; TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEINS;

EID: 84867886709     PISSN: 00468177     EISSN: 15328392     Source Type: Journal    
DOI: 10.1016/j.humpath.2012.03.019     Document Type: Article

References (20)

1. A. Jemal, F. Bray, M.M. Center, J. Ferlay, E. Ward, and D. Forman Global cancer statistics CA Cancer J Clin 61 2011 69 90
2. A. Okines, B. Sharma, and D. Cunningham Perioperative management of esophageal cancer Nat Rev Clin Oncol 7 2010 231 238
3. O. Kaufmann, E. Fietze, J. Mengs, and M. Dietel Value of p63 and cytokeratin 5/6 as immunohistochemical markers for the differential diagnosis of poorly differentiated and undifferentiated carcinomas Am J Clin Pathol 116 2001 823 830
4. J.N. Glickman, A. Yang, A. Shahsafaei, F. McKeon, and R.D. Odze Expression of p53-related protein p63 in the gastrointestinal tract and in esophageal metaplastic and neoplastic disorders Hum Pathol 32 2001 1157 1165
5. R.W. Werling, H. Yaziji, C.E. Bacchi, and A.M. Gown CDX2, a highly sensitive and specific marker of adenocarcinomas of intestinal origin: an immunohistochemical survey of 476 primary and metastatic carcinomas Am J Surg Pathol 27 2003 303 310
6. M.G. van Lier, F.J. Bomhof, I. Leendertse, M. Flens, A.T. Balk, and R.J. Loffeld Cytokeratin phenotyping does not help in distinguishing oesophageal adenocarcinoma from cancer of the gastric cardia J Clin Pathol 58 2005 722 724
7. A. Driessen, P. Nafteux, and T. Lerut Identical cytokeratin expression pattern CK7 +/CK20- in esophageal and cardiac cancer: etiopathological and clinical implications Mod Pathol 17 2004 49 55
8. U. Flucke, E. Steinborn, and V. Dries Immunoreactivity of cytokeratins (CK7, CK20) and mucin peptide core antigens (MUC1, MUC2, MUC5AC) in adenocarcinomas, normal and metaplastic tissues of the distal oesophagus, oesophago-gastric junction and proximal stomach Histopathology 43 2003 127 134
9. S. Szachnowicz, I. Cecconello, and U. Ribeiro Mucin pattern reflects the origin of the adenocarcinoma in Barrett's esophagus: a retrospective clinical and laboratorial study World J Surg Oncol 7 2009 27
10. J. Que, T. Okubo, and J.R. Goldenring Multiple dose-dependent roles for Sox2 in the patterning and differentiation of anterior foregut endoderm Development 134 2007 2521 2531
11. K.B. Long, and J.L. Hornick SOX2 is highly expressed in squamous cell carcinomas of the gastrointestinal tract Hum Pathol 40 2009 1768 1773
12. E.L. Maresh, V. Mah, and M. Alavi Differential expression of anterior gradient gene AGR2 in prostate cancer BMC Cancer 10 2010 680
13. M. Pizzi, M. Fassan, M. Balistreri, A. Galligioni, F. Rea, and M. Rugge Anterior gradient 2 overexpression in lung adenocarcinoma Appl Immunohistochem Mol Morphol 20 2012 31 36
14. F.R. Fritzsche, E. Dahl, and S. Pahl Prognostic relevance of AGR2 expression in breast cancer Clin Cancer Res 12 2006 1728 1734
15. H. Bu, S. Bormann, and G. Schafer The anterior gradient 2 (AGR2) gene is overexpressed in prostate cancer and may be useful as a urine sediment marker for prostate cancer detection Prostate 71 2011 575 587
16. A. Dong, A. Gupta, R.K. Pai, M. Tun, and A.W. Lowe The human adenocarcinoma-associated gene, AGR2, induces expression of amphiregulin through Hippo pathway co-activator YAP1 activation J Biol Chem 286 2011 18301 18310
17. E. Montgomery, J.K. Field, P. Boffetta, Y. Daigo, M. Shimizu, and T. Shimoda Squamous cell carcinoma of the esophagus F.T. Bosman, F. Carneiro, R.H. Hruban, N.D. Theise, WHO classification of tumours of the digestive system 4th ed. 2010 IARC Press Lyon, France 18 24
18. J.F. Flejou, R.D. Odze, and E. Montgomery Adenocarcinoma of the esophagus F.T. Bosman, F. Carneiro, R.H. Hruban, N.D. Theise, WHO classification of tumours of the digestive system 4th ed. 2010 IARC Press Lyon, France 25 31
19. R. Arnold, C. Capella, D.S. Klimstra, G. Kloppel, P. Komminoth, and E. Solcia Neuroendocrine neoplasms of the esophagus F.T. Bosman, F. Carneiro, R.H. Hruban, N.D. Theise, WHO classification of tumours of the digestive system 4th ed. 2010 IARC Press Lyon, France 32 34
20. C.L. Liu, W. Prapong, and Y. Natkunam Software tools for high-throughput analysis and archiving of immunohistochemistry staining data obtained with tissue microarrays Am J Pathol 161 2002 Nov 1557 1565